Vertex
Vertex Pharmaceuticals is a Boston-based biopharmaceutical company well-known for its groundbreaking work against cystic fibrosis, for its stellar financial performance, and for controversies surrounding drug pricing. It is currently researching treatments for sickle cell, chronic pain, muscular dystrophy, diabetes and more.
Latest
STAT Plus: Can gene therapies make for a profitable business? Keep your eye on Bluebird Bio
STAT Plus: Vertex pain drug results met with measured optimism — and questions — by observers and experts
STAT Plus: Vertex’s closely watched pain relief drug succeeds in late-stage trials — with a catch
STAT Plus: No pain data yet from Vertex, and sky high deal expectations at JPM 2024
After ‘SNL’ skit on sickle cell CRISPR therapy, advocates cite errors and stereotypes
Listen: FTC v. biotech, Pfizer’s kitchen sink, & Vertex’s future
STAT Plus: After decade-long dispute over CRISPR-Cas9, Editas strikes deal with Vertex to cash in
All Coverage
advertisement
